Document is current

Any future updates will be listed below

Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis

Crossref DOI link: https://doi.org/10.1007/s12282-015-0631-x

Published Online: 2015-08-13

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark